Stage IV Renal Cell Cancer AJCC v8 Clinical Trials in Pittsburgh, Pennsylvania

4 studies are recruiting for stage iv renal cell cancer ajcc v8 in Pittsburgh, Pennsylvania right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

    This phase II trial tests whether the addition of radiation to the primary tumor, typically given with stereotactic ablative radiation therapy (SABR), in combination with standard of care immunotherapy improves outcomes in patients with renal cell cancer that is not recommended for surgery and has …

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Allegheny General Hospital, Pittsburgh, Pennsylvania
    Locations
    328 in total
    Run by
    NRG Oncology

    See if you can join NCT05327686 on ClinicalTrials.gov

  2. Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

    This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from where it first started (primary site) to other places in the body. Cabozantinib may stop the growth of tumor cells by bl…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania
    Locations
    581 in total
    Run by
    National Cancer Institute (NCI)

    See if you can join NCT03866382 on ClinicalTrials.gov

  3. Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer

    This phase II trial studies the effects of combination therapy with bevacizumab, erlotinib, and atezolizumab in treating patients with hereditary leiomyomatosis and kidney cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced).…

    Stage
    Phase 2
    Ages
    12 and older
    Site
    UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania
    Locations
    13 in total
    Run by
    National Cancer Institute (NCI)

    See if you can join NCT04981509 on ClinicalTrials.gov

  4. Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

    This phase III trial compares the effect of adding surgery to a standard of care immunotherapy-based drug combination versus a standard of care immunotherapy-based drug combination alone in treating patients with kidney cancer that has spread to other places in the body (metastatic). Immunotherapy …

    Stage
    Phase 3
    Ages
    18 and older
    Site
    UPMC-Saint Margaret, Pittsburgh, Pennsylvania
    Locations
    387 in total
    Run by
    SWOG Cancer Research Network

    See if you can join NCT04510597 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.